GRP
AQST icon

Global Retirement Partners’s Aquestive Therapeutics AQST Stock Holding History

Global Retirement Partners’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29 Buy
+7
New +$29 ﹤0.01% 4483
2024
Q4 		$2.67K Sell
750
-750
-50% -$3.46K ﹤0.01% 2969
2024
Q3 		$7.47K Sell
1,500
-1,500
-50% -$5.84K ﹤0.01% 2400
2024
Q2 		$7.8K Buy
+3,000
New +$10K ﹤0.01% 2422

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Global Retirement Partners's AQST Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Aquestive Therapeutics (AQST) in Q2 2026: 7 shares worth $29. The stake represents ﹤0.01% of the portfolio and ranks #4483 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in AQST as recently as Q4 2024.

Global Retirement Partners first reported a position in AQST in Q2 2024 and has held it in 4 quarters since. The position peaked at $7.8K in Q2 2024. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Global Retirement Partners held 7 shares of Aquestive Therapeutics worth $29 as of Q2 2026.
  • Aquestive Therapeutics was a new Global Retirement Partners position in Q2 2026.
  • Aquestive Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #4483 holding.
  • Global Retirement Partners first reported a position in Aquestive Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Global Retirement Partners's Aquestive Therapeutics position peaked at $7.8K in Q2 2024.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.